Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Radiographics ; 38(2): 566-580, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29528815

RESUMEN

Neuroblastoma is an embryonic tumor of the peripheral sympathetic nervous system. It is the most common extracranial solid tumor of childhood and accounts for up to 15% of all pediatric cancer fatalities. The manifestation of neuroblastoma is variable depending on the location of the tumor and on the presence or absence of paraneoplastic syndromes. The prognosis of neuroblastoma is also highly variable, ranging from spontaneous regression to widespread metastatic disease that is unresponsive to treatment. The age of the patient, stage of disease, histopathologic results, and multiple biologic factors contribute to the presurgical and pretreatment risk stratification of a patient with neuroblastoma. Multimodality anatomic imaging with ultrasonography, computed tomography, and magnetic resonance imaging, as well as functional or metabolic nuclear imaging, are essential to determining the risk status of a patient with neuroblastoma. Patients at low risk of metastasis or death receive minimal intervention and those at high risk receive multimodality treatment. New immunotherapeutic techniques and nuclear medicine-targeted therapies have emerged and are demonstrating promising response rates for patients at high risk. This article reviews updates in the diagnosis, management, and treatment of neuroblastoma that have evolved over the past 2 decades, including emphasis on presurgical risk stratification, genetic evaluation of tumors, and the use of modern, high-quality, advanced imaging modalities. ©RSNA, 2018.


Asunto(s)
Neuroblastoma/diagnóstico por imagen , Terapia Combinada , Diagnóstico Diferencial , Humanos , Estadificación de Neoplasias , Neuroblastoma/genética , Neuroblastoma/patología , Neuroblastoma/terapia , Pronóstico , Medición de Riesgo
2.
Clin Imaging ; 71: 117-120, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-33190058

RESUMEN

Nevus of Ota, also known as oculodermal melanocytosis, is a benign melanocytic lesion that develops along the distribution of the V1 and V2 branches of the trigeminal nerve. Prior reports have described the typical imaging and clinical features of nevus of Ota. We present a rare case of a 31 year-old female with midface tumors and presumed hemorrhage into an orbital lesion in the setting of nevus of Ota resulting in acute loss of vision.


Asunto(s)
Nevo de Ota , Neoplasias Cutáneas , Adulto , Diagnóstico por Imagen , Femenino , Humanos , Nevo de Ota/diagnóstico por imagen , Nervio Trigémino
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA